Loading...
Alcon Inc.
ALC•NYSE
Healthcare
Medical - Instruments & Supplies
$87.81
$0.70(0.80%)
Alcon Inc. (ALC) Financial Performance & Statements
Review Alcon Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.82%
↑ 4.82%
Operating Income Growth
36.00%
↑ 36.00%
Net Income Growth
4.52%
↑ 4.52%
Operating Cash Flow Growth
49.64%
↑ 49.64%
Operating Margin
15.22%
↑ 15.22%
Gross Margin
55.55%
↑ 55.55%
Net Profit Margin
11.27%
↑ 11.27%
ROE
6.95%
↑ 6.95%
ROIC
5.26%
↑ 5.26%
Alcon Inc. (ALC) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Alcon Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.50B | $2.45B | $2.51B | $2.46B |
| Cost of Revenue | $1.12B | $1.08B | $1.13B | $1.08B |
| Gross Profit | $1.39B | $1.37B | $1.38B | $1.38B |
| Gross Profit Ratio | $0.55 | $0.56 | $0.55 | $0.56 |
| R&D Expenses | $232.00M | $225.00M | $220.00M | $199.00M |
| SG&A Expenses | $802.00M | $809.00M | $837.00M | $802.00M |
| Operating Expenses | $990.00M | $1.04B | $1.06B | $1.01B |
| Total Costs & Expenses | $2.11B | $2.12B | $2.18B | $2.09B |
| Interest Income | $38.00M | $10.00M | $12.00M | $12.00M |
| Interest Expense | $48.00M | $49.00M | $50.00M | $45.00M |
| Depreciation & Amortization | $298.52M | $9.00M | $311.00M | $287.86M |
| EBITDA | $688.82M | $341.00M | $641.00M | $656.16M |
| EBITDA Ratio | $0.28 | $0.14 | $0.26 | $0.27 |
| Operating Income | $395.00M | $332.00M | $318.00M | $368.00M |
| Operating Income Ratio | $0.16 | $0.14 | $0.13 | $0.15 |
| Other Income/Expenses (Net) | -$46.00M | -$40.00M | -$38.00M | -$33.00M |
| Income Before Tax | $349.00M | $292.00M | $280.00M | $335.00M |
| Income Before Tax Ratio | $0.14 | $0.12 | $0.11 | $0.14 |
| Income Tax Expense | $65.00M | $29.00M | $57.00M | $87.00M |
| Net Income | $284.00M | $263.00M | $223.00M | $248.00M |
| Net Income Ratio | $0.11 | $0.11 | $0.09 | $0.10 |
| EPS | $0.57 | $0.53 | $0.45 | $0.50 |
| Diluted EPS | $0.57 | $0.53 | $0.45 | $0.50 |
| Weighted Avg Shares Outstanding | $494.40M | $494.60M | $494.50M | $493.80M |
| Weighted Avg Shares Outstanding (Diluted) | $497.50M | $497.70M | $497.00M | $496.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan